TRENDING WELLNESS TOPIC: Medical Management of Obesity

What is the problem?

Obesity is a common, serious, and costly disease. In the United States, the obesity prevalence is approximately 42%, and the severe obesity prevalence is 9.2%. Obesity is a risk factor for heart disease, stroke, type 2 diabetes, and certain types of cancer. The treatment of obesity is evolving as a new class of medications- GLP1 analogues- have been approved for the treatment of obesity. Their efficacy has led to widespread use necessitating a greater understanding of indications, contraindications, use and adverse effects. Understanding the evidence-based use of these medications is critical to treating patients with obesity.

Learning Objectives

1. Understand the pathophysiology of obesity
2. Understand the role of diet, exercise and sleep in weight management.
3. Learn the current FDA-approved anti-obesity pharmacotherapy
4. Learn how to effectively employ anti-obesity pharmacotherapy in the clinical setting for the treatment of overweight and obesity.
5. Understand how weight bias impacts patient morbidity, mortality and access to care

CLICK HERE to download a PDF file featuring information gaps, potential needs, and references for this topic.

If your medical staff needs an update on managing obesity, consider contacting our office to book a speaker at 877-505-4777 or info@speakersnetwork.com.

REFERENCES

https://www.cdc.gov/obesity/data/adult.html
Risks of Ozempic, Wegovy and Other Weight Loss Drugs for People Over 65 – The New York Times (nytimes.com)

Barnes LL, de Leon CF, Lewis TT, Bienias JL, Wilson RS, Evans DA. Perceived discrimination and mortality

in a population-based study of older adults. Am J Public Health. 2008 Jul;98(7):1241-7. doi:

10.2105/AJPH.2007.114397. Epub 2008 May 29. PMID: 18511732; PMCID: PMC2424090

Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public
Health. 2009;9:88. doi: 10.1186/1471-2458-9-88.

Schienkiewitz A, Mensink GB, Scheidt-Nave C. Comorbidity of overweight and obesity in a nationally representative sample of German adults aged 18-79 years. BMC Public Health. 2012;12:658.
doi: 10.1186/1471